Reframing MFA Bypass: Four Identity Gaps Attackers Exploit
The misnomer of ‘MFA Bypass’ keeps MFA at the center of a problem it cannot solve alone. Continue reading →
123,000 Impacted by American Lending Center’s Year-Old Breach
The American Lending Center notified consumers of a data breach nearly a year after it occured. Continue reading →Merck ADC, licensed from China, hits mark in first big global trial
The endometrial cancer trial is the first of 17 late-stage studies Merck is running for a therapy that’s important to its ambitions of hitting $70 billion in annual sales next decade. Continue reading →FDA approves AstraZeneca’s new kind of hypertension drug
Baxfendy inhibits a blood-pressure-raising enzyme and, according to AstraZeneca executives, is poised to be a “big product” that should ultimately generate $5 billion or more in annual sales. Continue reading →Relay drug shows early promise against rare blood vessel diseases
While early, the findings suggest the therapy could be superior to Novartis’ Vijoice at treating “vascular anomalies,” a cluster of chronic conditions with few available treatments. Continue reading →
Eroding ACA Enrollment Portends Higher Insurance Rates
Enrollment in the Affordable Care Act continues to erode as some customers struggle to make premium payments, with the declining numbers churning market uncertainty for insurers. In response, insurers are likely to raise rates again next year, following this year’s larger-than-typical...
Bella Hadid Styles an Early 2000s Throwback for Chopard’s The Miracle Gala
The model wore a gold gown from Elie Saab’s fall 2004 collection. Continue reading →
Chanel and Tribeca Announce Third Annual ‘Through Her Lens’ Conversation
Teyana Taylor will participate in the conversation, part of Tribeca’s 25th Anniversary Storytellers Series, on June 7. Continue reading →